Miladi Saoussen, Belhadj Wiem, Boussaa Hiba, Yasmine Makhlouf, Leith Zakraoui, Abdelghani Kawther Ben, Fazaa Alia, Laatar Ahmed
University of Tunis El Manar, Faculty of Medicine of Tunis, Mongi Slim Hospital, Rheumatology Department, Tunisia.
Reumatologia. 2023;61(1):38-44. doi: 10.5114/reum/161575. Epub 2023 Mar 8.
Shared decision-making between rheumatologists and patients has become an overarching principle in current treatment recommendations in rheumatoid arthritis (RA). Therefore, in the present study, we aimed to assess the satisfaction of patients with RA with their treatment and to investigate the associated factors.
A cross-sectional study was carried out in the Rheumatology Department of Mongi Slim Hospital. We included adults with RA receiving their current disease-modifying anti-rheumatic drugs for at least 12 months.Satisfaction among patients was assessed by the Treatment Satisfaction Questionnaire for Medication (TSQM) and it was defined by a score ≥ 80%. The factors indirectly influencing patient satisfaction that were assessed were: satisfaction with medical care management, disease activity, functional impact, professional impact, and the impact of RA. Multivariable regression analysis was applied to determine the predictors of satisfaction.
We included 70 patients (63 female/7 male) with a mean age of 57.8 ±10.6 years. The mean disease duration was 13.71 ±7.2 years.Mean TSQM scores were 65.42 ±14.77 for convenience, 68.71 ±18 for effectiveness, 70.60 ±24.5 for side effects, and 67.95 ±17.10 for global satisfaction. Satisfaction rates were: 20% for convenience, 39% for effectiveness, 46% for side effects and 30% for global satisfaction.In multivariable analysis, the predictors of global dissatisfaction were Rheumatoid Arthritis Impact of Disease (RAID) overall score ( = 0.003) and the degree of physical difficulties ( = 0.001). Satisfaction with the physician was correlated with better global satisfaction ( = 0.029). Difficulties in adapting to RA ( = 0.043) and current treatment with biologics ( = 0.027) were predictors of dissatisfaction with convenience. Predictors of dissatisfaction with efficiency were the RAID overall score ( = 0.032) and the difficulties of adapting to RA ( = 0.013). The predictors of satisfaction with side effects were a lower degree of interference with domestic work ( = 0.02) and better involvement of the patient in the treatment decision ( = 0.014).
The satisfaction with the attending physician, the participation in the treatment decision, and the impact of RA seem to influence treatment satisfaction the most. These data suggest that a better understanding of patients' medical needs and preferences would improve satisfaction outcomes.
在类风湿关节炎(RA)的当前治疗建议中,风湿病学家与患者之间的共同决策已成为一项首要原则。因此,在本研究中,我们旨在评估RA患者对其治疗的满意度,并调查相关因素。
在蒙吉·斯利姆医院风湿病科进行了一项横断面研究。我们纳入了正在接受当前抗风湿药物治疗至少12个月的成年RA患者。通过药物治疗满意度问卷(TSQM)评估患者的满意度,满意度定义为得分≥80%。评估的间接影响患者满意度的因素包括:对医疗管理的满意度、疾病活动度、功能影响、专业影响以及RA的影响。应用多变量回归分析来确定满意度的预测因素。
我们纳入了70例患者(63例女性/7例男性),平均年龄为57.8±10.6岁。平均病程为13.71±7.2年。便利性方面的平均TSQM评分为65.42±14.77,有效性方面为68.71±18,副作用方面为70.60±24.5,总体满意度方面为67.95±17.10。满意度分别为:便利性20%,有效性39%,副作用46%,总体满意度30%。在多变量分析中,总体不满意的预测因素是疾病对类风湿关节炎的影响(RAID)总分(P = 0.003)和身体困难程度(P = 0.001)。对医生的满意度与更好的总体满意度相关(P = 0.029)。适应RA的困难(P = 0.043)和目前使用生物制剂治疗(P = 0.027)是便利性不满意的预测因素。效率不满意的预测因素是RAID总分(P = 0.032)和适应RA的困难(P = 0.013)。副作用满意度的预测因素是对家务干扰程度较低(P = 0.02)和患者更好地参与治疗决策(P = 0.014)。
对主治医生的满意度、参与治疗决策以及RA的影响似乎对治疗满意度影响最大。这些数据表明,更好地了解患者的医疗需求和偏好将改善满意度结果。